Abstract
The muscle disease field has benefited enormously from the increasing availability of genomic resources derived from the human genome mapping and allied projects. Although a number of skeletal and cardiac disorders are still at the linkage or candidate gene analysis stage, genes have been identified for the most common ones. The increasing variety of genes involved makes genetic screens an essential tool for more precise diagnosis and better classification of these disorders. The mouse represents the system of choice for the study of muscular dystrophies and cardiomyopathies but, not surprisingly, many murine models often show phenotypic differences between human and mouse. Only a handful of spontaneous or targeted mouse mutants are available within the field of muscle diseases compared to the increasing genetic complexity of myopathies and cardiomyopathies identified in humans. This shortage has been identified in other inherited diseases and has contributed to the revival of ENU (ethylnitrosourea) mutagenesis. Several large-scale ENU mutagenesis programs set up worldwide should provide allelic collections of mutants for pathologically interesting genes and uncover new gene functions. An effective integration between high throughput production of mutants, DNA-chip based expression analysis and the comprehensive maps derived from the human and mouse genome projects will make possible systematic studies of mammalian gene function, facilitating the identification of better mouse models.
Keywords: Muscle Diseases, Dystrophin glycoprotein complex DGC, Limb girdle Muscular dystrophy LGMD, Muscular dystrophy CMD, Cardiomyopathies, Mutagenesis, Muscle lim protein MLP
Current Genomics
Title: Inherited Muscle Diseases Towards Improvements of the Mouse Model Catalogue
Volume: 1 Issue: 3
Author(s): Gonzalo Blanco
Affiliation:
Keywords: Muscle Diseases, Dystrophin glycoprotein complex DGC, Limb girdle Muscular dystrophy LGMD, Muscular dystrophy CMD, Cardiomyopathies, Mutagenesis, Muscle lim protein MLP
Abstract: The muscle disease field has benefited enormously from the increasing availability of genomic resources derived from the human genome mapping and allied projects. Although a number of skeletal and cardiac disorders are still at the linkage or candidate gene analysis stage, genes have been identified for the most common ones. The increasing variety of genes involved makes genetic screens an essential tool for more precise diagnosis and better classification of these disorders. The mouse represents the system of choice for the study of muscular dystrophies and cardiomyopathies but, not surprisingly, many murine models often show phenotypic differences between human and mouse. Only a handful of spontaneous or targeted mouse mutants are available within the field of muscle diseases compared to the increasing genetic complexity of myopathies and cardiomyopathies identified in humans. This shortage has been identified in other inherited diseases and has contributed to the revival of ENU (ethylnitrosourea) mutagenesis. Several large-scale ENU mutagenesis programs set up worldwide should provide allelic collections of mutants for pathologically interesting genes and uncover new gene functions. An effective integration between high throughput production of mutants, DNA-chip based expression analysis and the comprehensive maps derived from the human and mouse genome projects will make possible systematic studies of mammalian gene function, facilitating the identification of better mouse models.
Export Options
About this article
Cite this article as:
Blanco Gonzalo, Inherited Muscle Diseases Towards Improvements of the Mouse Model Catalogue, Current Genomics 2000; 1 (3) . https://dx.doi.org/10.2174/1389202003351427
DOI https://dx.doi.org/10.2174/1389202003351427 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Risk Profiles in Type 2 Diabetes (Metabolic Syndrome): Integration of IL-10 Polymorphisms and Laboratory Parameters to Identify Vascular Damages Related Complications
Current Pharmaceutical Design Pharmacotherapy in Neonatal and Pediatric Extracorporeal Membrane Oxygenation (ECMO)
Current Drug Metabolism NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment
Current Medicinal Chemistry Meet Our Editorial Board Member:
Current Vascular Pharmacology Melatonin-mitochondria Interplay in Health and Disease
Current Topics in Medicinal Chemistry Role of Carbon Monoxide in Vascular Diseases
Current Pharmaceutical Biotechnology The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential
Current Medicinal Chemistry Regulation of Angiotensin II Receptor Expression
Current Pharmaceutical Design Approaches Used in Immunotherapy for Prostate Cancer
Current Cancer Therapy Reviews Cardiac Tumors: Clinical Perspective and Therapeutic Considerations
Current Drug Targets Calcium Ions in Inherited Cardiomyopathies
Medicinal Chemistry Withdrawal Notice: Therapeutic Options for Treatment of COVID-19: A Review from Repurposed Drugs to New Drug Targets
Current Drug Targets Rac-1 as a New Therapeutic Target in Cerebro- and Cardio-Vascular Diseases
Current Drug Targets Prediction of Disease-Related Genes Based on Hybrid Features
Current Proteomics Hybrid Stress Testing by Adenosine Infusion and Exercise Myocardial Perfusion Imaging: A Critical Appraisal
Current Cardiology Reviews Evolution and Analysis of Heterogeneity in the Clinical Expression of Aortic Diseases Similar to Marfan’s Syndrome: Challenge and Art in Clinical Diagnosis
Current Rheumatology Reviews HER-2 Signaling and Inhibition in Breast Cancer
Current Cancer Drug Targets Myocardial Inflammation in Autoimmune Diseases: Investigation by Cardiovascular Magnetic Resonance and Endomyocardial Biopsy
Inflammation & Allergy - Drug Targets (Discontinued) The Potential Role of Erythropoietin as a Pleiotropic Agent in Post-cardiac Arrest Syndrome
Current Pharmaceutical Design Bioactive Compounds in Diabetic Cardiomyopathy: Current Approaches and Potential Diagnostic and Therapeutic Targets
Cardiovascular & Hematological Agents in Medicinal Chemistry